Aytu Bioscience
Englewood, US · 1 known investors
Biopharmaceutical company that went public on NASDAQ in 2021 (AADI)
Biotech
Founders & leadership
JT
Jarrett T. DisbrowExecutive Officer
MA
Michael A. MacalusoDirector
JR
Joshua R. DisbrowExecutive Officer
GA
Gregory A. GouldExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$10MraisedOct 2019 · 2 investors · Pharmaceuticals
Rule 506(b)$11.8MraisedAug 2017 · 70 investors · Pharmaceuticals
Rule 506(b)$1.8MraisedMay 2017 · 16 investors · Pharmaceuticals
Rule 506(b)$5.2MraisedSep 2015 · 96 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.